GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngene International Ltd (BOM:539268) » Definitions » Equity-to-Asset

Syngene International (BOM:539268) Equity-to-Asset : 0.69 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Syngene International's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹42,577 Mil. Syngene International's Total Assets for the quarter that ended in Mar. 2024 was ₹61,516 Mil. Therefore, Syngene International's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.69.

The historical rank and industry rank for Syngene International's Equity-to-Asset or its related term are showing as below:

BOM:539268' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.44   Med: 0.57   Max: 0.68
Current: 0.67

During the past 13 years, the highest Equity to Asset Ratio of Syngene International was 0.68. The lowest was 0.44. And the median was 0.57.

BOM:539268's Equity-to-Asset is ranked better than
50.86% of 1565 companies
in the Biotechnology industry
Industry Median: 0.67 vs BOM:539268: 0.67

Syngene International Equity-to-Asset Historical Data

The historical data trend for Syngene International's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngene International Equity-to-Asset Chart

Syngene International Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.52 0.58 0.59 0.62 0.69

Syngene International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.62 - 0.67 - 0.69

Competitive Comparison of Syngene International's Equity-to-Asset

For the Biotechnology subindustry, Syngene International's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngene International's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngene International's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Syngene International's Equity-to-Asset falls into.



Syngene International Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Syngene International's Equity to Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Equity to Asset (A: Mar. 2024 )=Total Stockholders Equity/Total Assets
=42577/61516
=0.69

Syngene International's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=42577/61516
=0.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syngene International  (BOM:539268) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Syngene International Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Syngene International's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International (BOM:539268) Business Description

Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International (BOM:539268) Headlines

No Headlines